Quintiles Transitional Holdings Inc. (NYSE:Q) was downgraded by equities research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a note issued to investors on Friday.

Several other analysts also recently weighed in on the stock. Zacks Investment Research downgraded shares of Quintiles Transitional Holdings from a “hold” rating to a “sell” rating in a report on Wednesday, April 26th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $81.00 target price (up previously from $78.00) on shares of Quintiles Transitional Holdings in a report on Friday, May 5th. Mizuho lifted their target price on shares of Quintiles Transitional Holdings from $90.00 to $93.00 and gave the company a “buy” rating in a report on Thursday, May 4th. Citigroup Inc. reaffirmed a “neutral” rating and issued a $96.00 target price (up previously from $87.00) on shares of Quintiles Transitional Holdings in a report on Wednesday, June 28th. Finally, Robert W. Baird raised shares of Quintiles Transitional Holdings from an “underperform” rating to a “neutral” rating and lifted their target price for the company from $76.00 to $93.00 in a report on Friday, July 7th. Eleven analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $89.94.

Quintiles Transitional Holdings (NYSE Q) traded up 1.53% during midday trading on Friday, reaching $88.91. 1,006,508 shares of the company’s stock traded hands. The company has a market capitalization of $19.25 billion, a PE ratio of 257.71 and a beta of 0.64. Quintiles Transitional Holdings has a 1-year low of $70.10 and a 1-year high of $93.53. The firm’s 50 day moving average price is $90.01 and its 200-day moving average price is $83.51.

Quintiles Transitional Holdings (NYSE:Q) last posted its quarterly earnings data on Thursday, August 3rd. The medical research company reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.04. The company had revenue of $1.97 billion for the quarter, compared to analyst estimates of $1.96 billion. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 14.23%. Quintiles Transitional Holdings’s quarterly revenue was up 68.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.93 earnings per share. Equities analysts expect that Quintiles Transitional Holdings will post $4.58 EPS for the current year.

Quintiles Transitional Holdings announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, May 24th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the medical research company to buy up to 5.4% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s board of directors believes its shares are undervalued.

ILLEGAL ACTIVITY NOTICE: “BidaskClub Lowers Quintiles Transitional Holdings Inc. (NYSE:Q) to Buy” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark law. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/12/bidaskclub-lowers-quintiles-transitional-holdings-inc-nyseq-to-buy.html.

In other Quintiles Transitional Holdings news, major shareholder Cpp Investment Board Private H sold 7,131,165 shares of the company’s stock in a transaction dated Wednesday, May 31st. The shares were sold at an average price of $84.01, for a total value of $599,089,171.65. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Ari Bousbib sold 92,160 shares of the company’s stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $90.35, for a total transaction of $8,326,656.00. Following the completion of the sale, the insider now directly owns 1,082,919 shares in the company, valued at approximately $97,841,731.65. The disclosure for this sale can be found here. Insiders sold 8,870,560 shares of company stock worth $745,916,241 in the last ninety days. Insiders own 6.40% of the company’s stock.

Several hedge funds have recently made changes to their positions in Q. Fiduciary Trust Co. purchased a new position in Quintiles Transitional Holdings during the second quarter worth $105,000. Korea Investment CORP raised its position in Quintiles Transitional Holdings by 142.5% in the second quarter. Korea Investment CORP now owns 1,370 shares of the medical research company’s stock worth $123,000 after buying an additional 805 shares in the last quarter. Global X Management Co. LLC raised its position in Quintiles Transitional Holdings by 30.8% in the first quarter. Global X Management Co. LLC now owns 1,469 shares of the medical research company’s stock worth $118,000 after buying an additional 346 shares in the last quarter. IFP Advisors Inc raised its position in Quintiles Transitional Holdings by 187.1% in the first quarter. IFP Advisors Inc now owns 1,774 shares of the medical research company’s stock worth $143,000 after buying an additional 1,156 shares in the last quarter. Finally, Citigroup Inc. raised its position in Quintiles Transitional Holdings by 15.5% in the second quarter. Citigroup Inc. now owns 1,858 shares of the medical research company’s stock worth $167,000 after buying an additional 250 shares in the last quarter. 91.83% of the stock is currently owned by institutional investors.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Analyst Recommendations for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.